Literature DB >> 28151589

From blast to bench: A translational mini-review of posttraumatic headache.

Laura S Moye1, Amynah A Pradhan1.   

Abstract

Current events within the military and professional sports have resulted in an increased recognition of the long-term and debilitating consequences of traumatic brain injury. Mild traumatic brain injury accounts for the majority of head injuries, and posttraumatic headache is the most common adverse effect. It is estimated that between 30% to 90% of traumatic brain injuries result in posttraumatic headache, and for a significant number of people this headache disorder can continue for up to and over a year post injury. Often, the most severe and chronic posttraumatic headache has a migraine-like phenotype and is difficult to resolve. In this review we discuss the preclinical findings from animal models of posttraumatic headache. We also describe potential mechanisms by which traumatic brain injury leads to chronic posttraumatic headache, including neuroinflammatory mediators and migraine-associated neuropeptides. There are surprisingly few preclinical studies that have investigated overlapping mechanisms between posttraumatic headache and migraine, especially considering the prevalence and debilitating nature of posttraumatic headache. Given this context, posttraumatic headache is a field with many emerging opportunities for growth. The frequency of posttraumatic headache in the general and military population is rising, and further preclinical research is required to understand, ameliorate, and treat this disabling disorder.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  hyperalgesia; mTBI; migraine; pain; rodent

Mesh:

Year:  2017        PMID: 28151589      PMCID: PMC5388575          DOI: 10.1002/jnr.24001

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  87 in total

Review 1.  Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment.

Authors:  Gary B Kaplan; Jennifer J Vasterling; Priyanka C Vedak
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 2.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

Review 3.  Repetitive head trauma, chronic traumatic encephalopathy and tau: Challenges in translating from mice to men.

Authors:  Joseph O Ojo; Benoit C Mouzon; Fiona Crawford
Journal:  Exp Neurol       Date:  2015-06-06       Impact factor: 5.330

4.  Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.

Authors:  Sajedeh Eftekhari; Christopher A Salvatore; Sara Johansson; Tsing-Bau Chen; Zhizhen Zeng; Lars Edvinsson
Journal:  Brain Res       Date:  2014-11-20       Impact factor: 3.252

Review 5.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

Review 6.  Traumatic brain injury, neuroinflammation, and post-traumatic headaches.

Authors:  Cynthia L Mayer; Bertrand R Huber; Elaine Peskind
Journal:  Headache       Date:  2013-07-08       Impact factor: 5.887

7.  Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI).

Authors:  Golam Mustafa; Jiamei Hou; Shigeharu Tsuda; Rachel Nelson; Ankita Sinharoy; Zachary Wilkie; Rahul Pandey; Robert M Caudle; John K Neubert; Floyd J Thompson; Prodip Bose
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

Review 8.  Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.

Authors:  Marcelo E Bigal; Sarah Walter; Alan M Rapoport
Journal:  Headache       Date:  2013-07-12       Impact factor: 5.887

9.  Prediction of headache severity (density and functional impact) after traumatic brain injury: A longitudinal multicenter study.

Authors:  William C Walker; Jennifer H Marwitz; Amber R Wilk; Jessica M Ketchum; Jeanne M Hoffman; Allen W Brown; Sylvia Lucas
Journal:  Cephalalgia       Date:  2013-04-10       Impact factor: 6.292

10.  Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.

Authors:  Peter S Amenta; Jack I Jallo; Ronald F Tuma; D Craig Hooper; Melanie B Elliott
Journal:  J Neuroinflammation       Date:  2014-11-22       Impact factor: 8.322

View more
  7 in total

1.  Delta opioid receptor agonists are effective for multiple types of headache disorders.

Authors:  Laura S Moye; Alycia F Tipton; Isaac Dripps; Zoie Sheets; Aimee Crombie; Jonathan D Violin; Amynah A Pradhan
Journal:  Neuropharmacology       Date:  2018-12-14       Impact factor: 5.250

Review 2.  Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence.

Authors:  Silvia Benemei; Alejandro Labastida-Ramírez; Ekaterina Abramova; Nicoletta Brunelli; Edoardo Caronna; Paola Diana; Roman Gapeshin; Maxi Dana Hofacker; Ilaria Maestrini; Enrique Martínez Pías; Petr Mikulenka; Olga Tikhonova; Paolo Martelletti; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2020-07-14       Impact factor: 7.277

3.  The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.

Authors:  Laura S Moye; Madeline L Novack; Alycia F Tipton; Harish Krishnan; Subhash C Pandey; Amynah Aa Pradhan
Journal:  Cephalalgia       Date:  2018-05-17       Impact factor: 6.292

4.  Emerging themes in idiopathic intracranial hypertension.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Zerin Alimajstorovic; Gareth G Lavery; Alexandra J Sinclair
Journal:  J Neurol       Date:  2020-07-22       Impact factor: 4.849

5.  Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.

Authors:  Andreas Yiangou; James L Mitchell; Claire Fisher; Julie Edwards; Vivek Vijay; Zerin Alimajstorovic; Olivia Grech; Gareth G Lavery; Susan P Mollan; Alexandra J Sinclair
Journal:  Headache       Date:  2020-12-14       Impact factor: 5.887

Review 6.  Getting on the Same Page: Consolidating Terminology to Facilitate Cross-Disciplinary Health-Related Blast Research.

Authors:  Jennifer N Belding; Michael Egnoto; Robyn M Englert; Shannon Fitzmaurice; Cynthia J Thomsen
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

7.  Identifying oxidized lipid mediators as prognostic biomarkers of chronic posttraumatic headache.

Authors:  Anthony F Domenichiello; Jennifer R Jensen; Daisy Zamora; Mark Horowitz; Zhi-Xin Yuan; Keturah Faurot; J Douglas Mann; Andrew J Mannes; Christopher E Ramsden
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.